Health
FDA authorizes marketing of new device designed to remove dead pancreatic tissue – FDA.gov
): FDA granted de novo for the EndoRotor System to resection (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis.
For Immediate Release:
December 23, 2020
Today, the U.S. Food and Drug Administration authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with walled-off pancreatic necrosis (WOPN), a potentially deadly condition which can occur several weeks after an episode of severe acute pancreatitis, often requiring tissue removal.
This device has shown its potential to provide a minimally invasive way to remove harmful necrotic pancreatic tissue…
-
General21 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
General15 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
Noosa News19 hours agoMeticulously crafted home in heart of Noosa Heads
-
General18 hours ago‘Mother’s Day’ solar storm squeezed Earth’s plasmasphere to one-fifth its size